Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02015221 · ClinicalTrials.gov registry record · NA
Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort
A NA study, sponsored by Tactile Medical.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT02015221: Completed NA study, sponsored by Tactile Medical.
NCT02015221 is a NA study that has completed, run by Tactile Medical. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02015221, a NA study, has completed, sponsored by Tactile Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.
Primary Outcome
Ease of application and removal (donning and doffing) the treatment at the baseline visit. Comfort of treatment after the treatment was first applied.
Interventions
- DEVICE Dual Action Pneumatic Compression Device
- DEVICE Standard Compression Garments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02015221 record still lists
NCT02015221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Dual Action Pneumatic Compression Device is the first listed.
NCT02015221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02015221 about?
NCT02015221 is a clinical study titled "Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort". The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.
What is the current status of trial NCT02015221?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2013-11. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02015221?
The interventions under investigation include: Dual Action Pneumatic Compression Device (DEVICE), Standard Compression Garments (DEVICE).
Who is sponsoring clinical trial NCT02015221?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02015221's enrollment target sits among peer trials
81 992nd of 2000 higher than 1,007 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia